Literature DB >> 24665101

Physiological underpinnings of irritable bowel syndrome: neurohormonal mechanisms.

Michael Camilleri1.   

Abstract

The gastrointestinal tract is a vast neuroendocrine organ with extensive extrinsic and intrinsic neural circuits that interact to control its function. Circulating and paracrine hormones (amine and peptide) provide further control of secretory, absorptive, barrier, motor and sensory mechanisms that are essential to the digestion and assimilation of nutrients, and the transport and excretion of waste products. Specialized elements of the mucosa (including enteroendocrine cells, enterocytes and immune cells) and the microbiome interact with other intraluminal contents derived from the diet, and with endogenous chemicals that alter the gut's functions. The totality of these control mechanisms is often summarized as the brain-gut axis. In irritable bowel syndrome (IBS), which is the most common gastrointestinal disorder, there may be disturbances at one or more of these diverse control mechanisms. Patients present with abdominal pain in association with altered bowel function. This review documents advances in understanding the pathophysiological mechanisms in the brain-gut axis in patients with IBS. It is anticipated that identification of one or more disordered functions in clinical practice will usher in a renaissance in the management of IBS, leading to effective therapy tailored to the needs of the individual patient.
© 2014 The Authors. The Journal of Physiology © 2014 The Physiological Society.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24665101      PMCID: PMC4214653          DOI: 10.1113/jphysiol.2014.270892

Source DB:  PubMed          Journal:  J Physiol        ISSN: 0022-3751            Impact factor:   5.182


  106 in total

1.  Effects of serotonin on intestinal secretion and motility.

Authors:  Robin C. Spiller
Journal:  Curr Opin Gastroenterol       Date:  2001-03       Impact factor: 3.287

Review 2.  New insights into visceral hypersensitivity--clinical implications in IBS.

Authors:  QiQi Zhou; G Nicholas Verne
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2011-06       Impact factor: 46.802

Review 3.  Peripheral mechanisms in irritable bowel syndrome.

Authors:  Michael Camilleri
Journal:  N Engl J Med       Date:  2012-10-25       Impact factor: 91.245

4.  Alterations in expression of p11 and SERT in mucosal biopsy specimens of patients with irritable bowel syndrome.

Authors:  Michael Camilleri; Christopher N Andrews; Adil E Bharucha; Paula J Carlson; Irene Ferber; Debra Stephens; Thomas C Smyrk; Raul Urrutia; Jeroen Aerssens; Leen Thielemans; Hinrich Göhlmann; Ilse van den Wyngaert; Bernard Coulie
Journal:  Gastroenterology       Date:  2006-11-17       Impact factor: 22.682

5.  Brain responses to visceral stimuli reflect visceral sensitivity thresholds in patients with irritable bowel syndrome.

Authors:  Mats B O Larsson; Kirsten Tillisch; A D Craig; Maria Engström; Jennifer Labus; Bruce Naliboff; Peter Lundberg; Magnus Ström; Emeran A Mayer; Susanna A Walter
Journal:  Gastroenterology       Date:  2011-11-19       Impact factor: 22.682

6.  Autonomic nervous system function in young children with functional abdominal pain or irritable bowel syndrome.

Authors:  Monica Jarrett; Margaret Heitkemper; Danita Czyzewski; Lonnie Zeltzer; Robert J Shulman
Journal:  J Pain       Date:  2012-04-20       Impact factor: 5.820

7.  Mucosal serotonin signaling is altered in chronic constipation but not in opiate-induced constipation.

Authors:  Meagan M Costedio; Matthew D Coates; Elice M Brooks; Lisa M Glass; Eric K Ganguly; Hagen Blaszyk; Allison L Ciolino; Michael J Wood; Doris Strader; Neil H Hyman; Peter L Moses; Gary M Mawe
Journal:  Am J Gastroenterol       Date:  2009-12-15       Impact factor: 10.864

8.  Consumption of fermented milk product with probiotic modulates brain activity.

Authors:  Kirsten Tillisch; Jennifer Labus; Lisa Kilpatrick; Zhiguo Jiang; Jean Stains; Bahar Ebrat; Denis Guyonnet; Sophie Legrain-Raspaud; Beatrice Trotin; Bruce Naliboff; Emeran A Mayer
Journal:  Gastroenterology       Date:  2013-03-06       Impact factor: 22.682

9.  Catecholamine and cortisol levels during sleep in women with irritable bowel syndrome.

Authors:  R L Burr; M E Jarrett; K C Cain; S-E Jun; M M Heitkemper
Journal:  Neurogastroenterol Motil       Date:  2009-07-01       Impact factor: 3.598

10.  Correlation between gastrointestinal hormones and anxiety-depressive states in irritable bowel syndrome.

Authors:  Baojuan Han
Journal:  Exp Ther Med       Date:  2013-07-09       Impact factor: 2.447

View more
  39 in total

Review 1.  Enteric nervous system development: A crest cell's journey from neural tube to colon.

Authors:  Nandor Nagy; Allan M Goldstein
Journal:  Semin Cell Dev Biol       Date:  2017-01-10       Impact factor: 7.727

2.  Colonic mucosal gene expression and genotype in irritable bowel syndrome patients with normal or elevated fecal bile acid excretion.

Authors:  Michael Camilleri; Paula Carlson; Andres Acosta; Irene Busciglio
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2015-04-30       Impact factor: 4.052

3.  A high prevalence of chronic gastrointestinal symptoms in adults with cystic fibrosis is detected using tools already validated in other GI disorders.

Authors:  Bu'Hussain Hayee; Kerry-Lee Watson; Sanchika Campbell; Anna Simpson; Emma Farrell; Penelope Hutchings; Patricia Macedo; Felicity Perrin; Kevin Whelan; Caroline Elston
Journal:  United European Gastroenterol J       Date:  2019-08       Impact factor: 4.623

Review 4.  Pathophysiology, Evaluation, and Management of Chronic Watery Diarrhea.

Authors:  Michael Camilleri; Joseph H Sellin; Kim E Barrett
Journal:  Gastroenterology       Date:  2016-10-20       Impact factor: 22.682

5.  Neurohormonal signalling in the gastrointestinal tract: new frontiers.

Authors:  Keith A Sharkey; Gary M Mawe
Journal:  J Physiol       Date:  2014-06-13       Impact factor: 5.182

Review 6.  Chemical and molecular factors in irritable bowel syndrome: current knowledge, challenges, and unanswered questions.

Authors:  Michael Camilleri; Ibironke Oduyebo; Houssam Halawi
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2016-09-08       Impact factor: 4.052

7.  Neuroimaging the brain-gut axis in patients with irritable bowel syndrome.

Authors:  Kristen R Weaver; LeeAnne B Sherwin; Brian Walitt; Gail D'Eramo Melkus; Wendy A Henderson
Journal:  World J Gastrointest Pharmacol Ther       Date:  2016-05-06

8.  Pilot study of small bowel mucosal gene expression in patients with irritable bowel syndrome with diarrhea.

Authors:  Michael Camilleri; Paula Carlson; Nelson Valentin; Andres Acosta; Jessica O'Neill; Deborah Eckert; Roy Dyer; Jie Na; Eric W Klee; Joseph A Murray
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2016-07-21       Impact factor: 4.052

9.  Reduction in duodenal endocrine cells in irritable bowel syndrome is associated with stem cell abnormalities.

Authors:  Magdy El-Salhy; Jan Gunnar Hatlebakk; Trygve Hausken
Journal:  World J Gastroenterol       Date:  2015-08-28       Impact factor: 5.742

10.  Genetic variation in GPBAR1 predisposes to quantitative changes in colonic transit and bile acid excretion.

Authors:  Michael Camilleri; Andrea Shin; Irene Busciglio; Paula Carlson; Andres Acosta; Adil E Bharucha; Duane Burton; Jesse Lamsam; Alan Lueke; Leslie J Donato; Alan R Zinsmeister
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2014-07-10       Impact factor: 4.052

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.